Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

NCT03191097 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Acute Respiratory Infection
Viral Infection
Common Cold

Interventions

DRUG: Ingavirin
DRUG: Placebo oral capsule

Sponsor

Valenta Pharm JSC

Collaborators

[object Object]